AMD
Advanced Micro Devices, Inc.
AMD has the edge over CRCT overall, supported by stronger modeled upside and stronger fundamentals.
CRCT
Cricut, Inc.
CRCT offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
AMD Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
AMD's revenue, profitability, cash flow and balance sheet are all currently strong.
CRCT Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
CRCT's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
AMD PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 39x | $585 | — |
| Cheap | 40x | $182 | -69% |
| Fair | 112x | $514 | -12% |
| Current | 127x | $585 | — |
| Expensive | 206x | $947 | +62% |
Historical ranges are pointers, not guarantees.
AMD's PE is in its fair range at 127x. If earnings grow as analysts expect, today's price would be 39x next year's earnings, in its cheap range.
CRCT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 14x | $6.15 | -28% |
| Current | 19x | $8.50 | — |
| Fair | 21x | $9.29 | +9.3% |
| Forward | 30x | $8.50 | — |
| Expensive | 34x | $15.24 | +79% |
Historical ranges are pointers, not guarantees.
CRCT has the edge over AMD in the historical PE scenario, which offers more potential upside but is not a forecast.
AMD Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Broad | |
| Low |
AMD has the edge over CRCT on the outlook, with more favorable valuation expectations.
CRCT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for CRCT, with profitability improving.
AMD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $15.05 | +227% |
| Q3 2026 | $4.60 | +127% |
| Q2 2026 | $3.89 | +122% |
| Q1 2026 | $3.05 | +123% |
| Q4 2025 | $2.65 | +165% |
| Q3 2025 | $2.03 | +81% |
| Q2 2025 | $1.75 | +111% |
| Q1 2025 | $1.37 | +99% |
| Q4 2024 | $1.00 | +89% |
AMD has the edge over CRCT on earnings, with stronger typical year-over-year growth.
CRCT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.28 | -38% |
| Q3 2026 | $0.45 | +18% |
| Q2 2026 | $0.42 | +27% |
| Q1 2026 | $0.34 | +9.7% |
| Q4 2025 | $0.35 | +21% |
| Q3 2025 | $0.38 | +36% |
| Q2 2025 | $0.33 | +6.5% |
| Q1 2025 | $0.31 | +6.9% |
| Q4 2024 | $0.29 | +21% |
CRCT's earnings per share have fallen from their peak: $0.45 over the past year, against $0.95 in mid-2021.
AMD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $13.4B | +45% |
| Q2 2026 | $11.5B | +50% |
| Q1 2026 | $10.3B | +38% |
| Q4 2025 | $10.3B | +34% |
| Q3 2025 | $9.2B | +36% |
| Q2 2025 | $7.7B | +32% |
| Q1 2025 | $7.4B | +36% |
| Q4 2024 | $7.7B | +24% |
AMD has the edge over CRCT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 21% | +7.4 points |
| Q2 2026 | 17% | +19 points |
| Q1 2026 | 14% | +3.6 points |
| Q4 2025 | 17% | +5.7 points |
| Q3 2025 | 14% | +3.1 points |
| Q2 2025 | -1.7% | -6.4 points |
| Q1 2025 | 11% | +10 points |
| Q4 2024 | 11% | +5.8 points |
AMD has the edge over CRCT on profitability, with a higher operating margin.
CRCT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $188.6M | +11% |
| Q2 2026 | $156.3M | -9.2% |
| Q1 2026 | $159.5M | -1.9% |
| Q4 2025 | $203.6M | -2.7% |
| Q3 2025 | $170.4M | +1.5% |
| Q2 2025 | $172.1M | +2.5% |
| Q1 2025 | $162.6M | -2.8% |
| Q4 2024 | $209.3M | -9.5% |
CRCT's revenue is recovering but still below its 2021 peak: $189M last quarter, up 11% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 18% | +4.7 points |
| Q2 2026 | 30% | +13 points |
| Q1 2026 | 14% | -3.7 points |
| Q4 2025 | 6.8% | +0.2 points |
| Q3 2025 | 13% | +7 points |
| Q2 2025 | 17% | +1.7 points |
| Q1 2025 | 18% | +3 points |
| Q4 2024 | 6.6% | -0.5 points |
CRCT's operating margin was 18% last quarter, up 4.7 points from the same quarter a year ago.
AMD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $554M | -71% |
| Q2 2026 | $1.6B | -9.9% |
| Q1 2026 | $2.6B | +253% |
| Q4 2025 | $2.4B | +118% |
| Q3 2025 | $1.9B | +283% |
| Q2 2025 | $1.7B | +294% |
| Q1 2025 | $727M | +92% |
| Q4 2024 | $1.1B | +351% |
AMD has the edge over CRCT on cash flow, with more consistent year-over-year improvement.
CRCT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $23.7M | +16% |
| Q2 2026 | $50.4M | +39% |
| Q1 2026 | $26.9M | -56% |
| Q4 2025 | $82.4M | -20% |
| Q3 2025 | $20.5M | -71% |
| Q2 2025 | $36.2M | +3.4% |
| Q1 2025 | $61.2M | +7.9% |
| Q4 2024 | $103.1M | +12% |
CRCT still generates free cash flow, though less than at its 2022 peak: $183M over the past year.
AMD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +2M shares |
| 1 year | +1.2% | +20M shares |
| 3 years | +2% | +32M shares |
| 5 years | +35% | +431M shares |
| Available history | +40% | +473M shares |
AMD has 1.7B diluted shares, up 1.2% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $221M |
| Q4 2025 | — |
| Q3 2025 | $89M |
| Q2 2025 | $478M |
| Q1 2025 | $749M |
| Q4 2024 | $256M |
AMD has spent almost nothing on buybacks in the past year.
CRCT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.8% | +1.7M shares |
| 1 year | -1.2% | -2.5M shares |
| 3 years | -3.5% | -7.6M shares |
| 5 years | -5.1% | -11.5M shares |
| Available history | -3.9% | -8.6M shares |
CRCT has the edge over AMD on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $5.9M |
| Q2 2026 | $7.5M |
| Q1 2026 | $12.3M |
| Q4 2025 | $5.7M |
| Q3 2025 | $2.4M |
| Q2 2025 | $4.7M |
| Q1 2025 | $12M |
| Q4 2024 | $8M |
CRCT spent $31M buying back its own shares over the past year, up 16% from the year before.
AMD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2020 | -1.0x | Net Cash |
| Q1 2020 | -0.8x | Net Cash |
| Q4 2019 | -1.2x | Net Cash |
AMD has more cash than debt.
CRCT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.2x | Net Cash |
| Q2 2026 | -2.0x | Net Cash |
| Q1 2026 | -2.1x | Net Cash |
| Q4 2025 | -2.1x | Net Cash |
| Q3 2025 | -1.6x | Net Cash |
| Q2 2025 | -2.7x | Net Cash |
| Q1 2025 | -2.3x | Net Cash |
| Q4 2024 | -2.2x | Net Cash |
CRCT has more cash than debt.
AMD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.3 | Neutral |
| Stochastic | 41.4 | Neutral |
AMD's weekly RSI is 59 (neutral) and its Stochastic is 41 (neutral).
CRCT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 76.4 | Overbought |
| Stochastic | 74.8 | Neutral |
CRCT's weekly RSI is 76 (overbought) and its Stochastic is 75 (neutral).
AMD PE vs Technology Sector
| Metric | AMD | Sector median | Relative |
|---|---|---|---|
| PE | 127x | 28x | 357% above |
| PE % | 61 | 35 | 26 pts above |
AMD is trading at 127x earnings, a 357% premium to the Technology sector's median of 28x.
CRCT PE vs Technology Sector
| Metric | CRCT | Sector median | Relative |
|---|---|---|---|
| PE | 19x | 28x | 32% below |
| PE % | 37 | 41 | 4 pts below |
CRCT has the edge over AMD on valuation relative to its sector.
AMD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $557.2 | 5.1% above |
| 20 week MA | $525.9 | 11% above |
| 50 week MA | $389.7 | 50% above |
| 100 week MA | $266.9 | 119% above |
| 200 week MA | $199.6 | 193% above |
AMD is in an uptrend: it's above all five of its weekly moving averages, and 193% above its 200-week average.
CRCT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $6.89 | 23% above |
| 20 week MA | $5.88 | 45% above |
| 50 week MA | $5.01 | 70% above |
| 100 week MA | $5.31 | 60% above |
| 200 week MA | $6.52 | 30% above |
CRCT has climbed back above all five of its weekly moving averages, and it's now 30% above its 200-week average.
AMD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $46.2 | $91.8 | +99% |
| 2021 | $91.8 | $146.1 | +59% |
| 2022 | $146.1 | $64.5 | -56% |
| 2023 | $64.5 | $147.4 | +128% |
| 2024 | $147.4 | $125.2 | -15% |
| 2025 | $125.2 | $215.0 | +72% |
| 2026 YTD | $215.0 | $585.3 | +172% |
AMD has the edge over CRCT on returns for 2026, with the stronger performance.
CRCT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $18.0 | $23.5 | +30% |
| 2022 | $23.5 | $10.1 | -57% |
| 2023 | $10.1 | $6.59 | -35% |
| 2024 | $6.59 | $5.75 | -13% |
| 2025 | $5.75 | $5.04 | -12% |
| 2026 YTD | $5.04 | $8.50 | +69% |
CRCT has finished four years in a row lower, and it's up 69% so far in 2026.